New insights into the Vitamin D requirements during pregnancy

Bone Research

Volumn 5, Issue , 2017, Pages

  Hollis, Bruce W ^a   Wagner, Carol L ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; BIOLOGICAL MARKER; VITAMIN D; VITAMIN D BINDING PROTEIN; VITAMIN D RECEPTOR;

ARTICLE; ASTHMA; FETUS OUTCOME; GENOMICS; GENOTYPE; HUMAN; INFLAMMATION; INTENTION TO TREAT ANALYSIS; LIFESTYLE; NUTRITIONAL REQUIREMENT; NUTRITIONAL STATUS; PLACENTA; PREGNANCY; PREGNANCY OUTCOME; PREGNANT WOMAN; RANDOMIZED CONTROLLED TRIAL (TOPIC); TROPHOBLAST; VITAMIN METABOLISM; VITAMIN SUPPLEMENTATION;

EID: 85028577053     PISSN: 20954700     EISSN: 20956231     Source Type: Journal    
DOI: 10.1038/boneres.2017.30     Document Type: Article

References (139)

1. Ross AC, Manson JE, Abrams SA et al. The 2011 Dietary Reference Intakes for Calcium and Vitamin D: what dietetics practitioners need to know. J Am Diet Assoc 2011; 111: 524-527.
2. World Health Organisation. Vitamin D Supplementation in Infants. Geneva: World Health Organisation. 2014.
3. De-Regil LM, Palacios C, Ansary A et al. Vitamin D supplementation for women during pregnancy. Cochrane Database Syst Rev 2012; 2: CD008873.
4. Heaney RP. Is vitamin D inadequacy in early life an instance of the "Barker Hypothesis"? Nutr Today 2016; 51: 14-17.
5. Camargo CA Jr, Ingham T, Wickens K et al. Cord-Blood 25-Hydroxyvitamin D levels and risk of respiratory infection, wheezing, and asthama. Pediatrics 2011; 127: e180-e187.
6. Litonjua AA. Childhood asthma may be a consequence of vitamin D deficiency. Curr Opin Allergy Clin Immunol 2009; 9: 202-207.
7. Munger KL, Aivo J, Hongell K et al. Vitamin D status during pregnancy and risk of multiple sclerosis in offspring of women in the Finnish Maternity Cohort. JAMA Neurol 2016; 73: 515-519.
8. Greenberg BM. Vitamin D during pregnancy and multiple sclerosis: an evolving association. JAMA Neurol 2016; 73: 498-499.
9. Dobson R, Giovannoni G, Ramagopalan S. The month of birth effect in multiple sclerosis: systematic review, meta-analysis and effect of latitude. J Neurol Neurosurg Psychiatry 2013; 84: 427-432.
10. Berlanga-Taylor AJ, Disanto G, Ebers GC et al. Vitamin D-gene interactions in multiple sclerosis. J Neurol Sci 2011; 311: 32-36.
11. Ebers G. Interactions of environment and genes in multiple sclerosis. J Neurol Sci 2013; 334: 161-163.
12. Stubbs G, Henley K, Green J. Autism: Will vitamin D supplementation during pregnancy and early childhood reduce the recurrence rate of autism in newborn siblings? Med Hypotheses 2016; 88: 74-78.
13. McGrath JJ, Eyles DW, Pedersen CB et al. Neonatal vitamin D status and risk of schizophrenia: a population-based case-control study. Arch Gen Psychiatry 2010; 67: 889-894.
14. Cannell JJ. Autism and vitamin D. Med Hypotheses 2008; 70: 750-759.
15. McGrath JJ, Féron FP, Burne TH et al. Vitamin D3-implications for brain development. J Steroid Biochem Mol Biol 2004; 89-90: 557-560.
16. Brannon PM, Picciano MF. Vitamin D in pregnancy and lactation in humans. Annu Rev Nutr 2011; 31: 89-115.
17. Abrams SA. Vitamin D supplementation during pregnancy. J Bone Miner Res 2011; 26: 2338-2340.
18. Heaney RP. Guidelines for optimizing design and analysis of clinical studies of nutrient effects. Nutr Rev 2014; 72: 48-54.
19. Tian XQ, Chen TC, Matsuoka LY et al. Kinetic and thermodynamic studies of the conversion of previtamin D3 to vitamin D3 in human skin. J Biol Chem 1993; 268: 14888-14892.
20. Vieth R, Bischoff-Ferrari H, Boucher B et al. The urgent need to recommend an intake of vitamin D that is effective. Am J Clin Nutr 2007; 85: 649-650.
21. Hollis B. Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr 2005; 135: 317-322.
22. Holick MF, Binkley NC, Bischoff-Ferrari HA et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2011; 96: 1911-1930.
23. Hollis BW, Wagner CL. Clinical review: the role of the parent compound vitamin D with respect to metabolism and function: why clinical dose intervals can affect clinical outcomes. J Clin Endocrinol Metab 2013; 98: 4619-4628.
24. Bikle DD, Gee E, Halloran B et al. Free 1,25-dihydroxyvitamin D levels in serum from normal subjects, pregnant subjects, and subjects with liver disease. J Clin Invest 1984; 74: 1966-1971.
25. Kumar R, Cohen WR, Silva P et al. Elevated 1,25-dihydroxyvitamin D plasma levels in normal human pregnancy and lactation. J Clin Invest 1979; 63: 342-344.
26. Lund B, Selnes A. Plasma 1,25-dihydroxyvitamin D levels in pregnancy and lactation. Acta Endocrinol 1979; 92: 330-335.
27. Steichen JJ, Tsang RC, Gratton TL et al. Vitamin D homeostasis in the perinatal period: 1,25-dihydroxyvitamin D in maternal, cord, and neonatal blood. N Engl J Med 1980; 302: 315-319.
28. Seino Y, Ishida M, Yamaoka K et al. Serum calcium regulating hormones in the perinatal period. Calcif Tissue Int 1982; 34: 131-135.
29. Heaney RP, Armas LA, Shary JR et al. 25-Hydroxylation of vitamin D3: relation to circulating vitamin D3 under various input conditions. Am J Clin Nutr 2008; 87: 1738-1742.
30. Hollis BW, Johnson D, Hulsey TC et al. Vitamin D supplementation during pregnancy: double-blind, randomized clinical trial of safety and effectiveness. J Bone Miner Res 2011; 26: 2341-2357.
31. Walker VP, Zhang X, Rastegar I et al. Cord blood vitamin D status impacts innate immune responses. J Clin Endocrinol Metab 2011; 96: 1835-1843.
32. Eichholzer M, Platz EA, Bienstock JL et al. Racial variation in vitamin D cord blood concentration in white and black male neonates. Cancer Causes Control 2013; 24: 91-98.
33. Kovacs CS. The role of vitamin D in pregnancy and lactation: insights from animal models and clinical studies. Annu Rev Nutr 2012; 32: 97-123.
34. Carneiro RM, Prebehalla L, Tedesco MB et al. Lactation and bone turnover: a conundrum of marked bone loss in the setting of coupled bone turnover. J Clin Endocrinol Metab 2010; 95: 1767-1776.
35. Bell NH, Stern PH, Pantzer E et al. Evidence that increased circulating 1 alpha, 25-dihydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis. J Clin Invest 1979; 64: 218-225.
36. Holick MF. The cutaneous photosynthesis of previtamin D3: a unique photoendocrine system. J Invest Dermatol 1981; 77: 51-58.
37. Hollander D, Muralidhara KS, Zimmerman A. Vitamin D3 intestinal absorption in vivo: influence of fatty acids, bile salts, and perfusate pH on absorption. Gut 1978; 19: 267-272.
38. Hollis BW, Lowery JW, Pittard WB 3rd et al. Effect of age on the intestinal absorption of vitamin D3-palmitate and nonesterified vitamin D2 in the term human infant. J Clin Endocrinol Metab 1996; 81: 1385-1388.
39. Heubi JE, Hollis BW, Specker B et al. Bone disease in chronic childhood cholestasis. I. Vitamin D absorption and metabolism. Hepatology 1989; 9: 258-264.
40. Haddad JG, Matsuoka LY, Hollis BW et al. Human plasma transport of vitamin D after its endogenous synthesis. J Clin Invest 1993; 91: 2552-2555.
41. Ponchon G, Kennan AL, DeLuca HF. "Activation" of vitamin D by the liver. J Clin Invest 1969; 48: 2032-2037.
42. Flanagan JN, Young MV, Persons KS et al. Vitamin D metabolism in human prostate cells: implications for prostate cancer chemoprevention by vitamin D. Anticancer Res 2006; 26: 2567-2572.
43. Karlgren M, Miura S, Ingelman-Sundberg M. Novel extrahepatic cytochrome P450s. Toxicol Appl Pharmacol 2005; 207: 57-61.
44. Hosseinpour F, Wikvall K. Porcine microsomal vitamin D(3) 25-hydroxylase (CYP2D25). Catalytic properties, tissue distribution, and comparison with human CYP2D6. J Biol Chem 2000; 275: 34650-34655.
45. Schuessler M, Astecker N, Herzig G et al. Skin is an autonomous organ in synthesis, two-step activation and degradation of vitamin D(3): CYP27 in epidermis completes the set of essential vitamin D(3)- hydroxylases. Steroids 2001; 66: 399-408.
46. Zhu J, DeLuca HF. Vitamin D 25-hydroxylase-four decades of searching, are we there yet? Arch Biochem Biophys 2012; 523: 30-36.
47. Smith JE, Goodman DS. The turnover and transport of vitamin D and of a polar metabolite with the properties of 25-hydroxycholecalciferol in human plasma. J Clin Invest 1971; 50: 2159-2167.
48. Bouillon R, van Baelen H, de Moor P. Comparative study of the affinity of the serum vitamin D-binding protein. J Steroid Biochem 1980; 13: 1029-1034.
49. Hollis BW. Comparison of equilibrium and disequilibrium assay conditions for ergocalceferol, cholecaliferol and their major metabolites. J Steroid Biochem 1984; 21: 81-86.
50. Kissmeyer A, Mathiasen IS, Latini S et al. Pharmacokinetic studies of vitamin D analogues: relationship to vitamin D binding protein (DBP). Endocrine 1995; 3: 263-266.
51. Vieth R, Kessler MJ, Pritzker KP. Species differences in the binding kinetics of 25-hydroxyvitamin D3 to vitamin D binding protein. Can J Physiol Pharmacol 1990; 68: 1368-1371.
52. Haddad JG, Hillman L, Rojanasathit S. Human serum binding capacity and affinity for 25-hydroxyergocalciferol and 25-hydroxycholecalciferol. J Clin Endocrinol Metab 1976; 43: 86-91.
53. Marzolo MP, Farfan P. New insights into the roles of megalin/LRP2 and the regulation of its functional expression. Biol Res 2011; 44: 89-105.
54. Nykjaer A, Dragun D, Walther D et al. An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell 1999; 96: 507-515.
55. Rasmussen H, Wong M, Bikle D et al. Hormonal control of the renal conversion of 25-hydroxycholecalciferol to 1,25-dihydroxycholecalciferol. J Clin Invest 1972; 51: 2502-2504.
56. Akour AA, Gerk P, Kennedy MJ. Megalin expression in human term and preterm placental villous tissues: effect of gestational age and sample processing and storage time. J Pharmacol Toxicol Methods 2015; 71: 147-154.
57. Jones AR, Shusta EV. Blood-brain barrier transport of therapeutics via receptor-mediation. Pharm Res 2007; 24: 1759-1771.
58. Safadi FF, Thornton P, Magiera H et al. Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein. J Clin Invest 1999; 103: 239.
59. Zella LA, Shevde NK, Hollis BW et al. Vitamin D-binding protein influences total circulating levels of 1,25-dihydroxyvitamin D3 but does not directly modulate the bioactive levels of the hormone in vivo. Endocrinology 2008; 149: 3656-3667.
60. Bodnar LM, Simhan HN, Catov JM et al. Maternal vitamin D status and the risk of mild and severe preeclampsia. Epidemiology 2014; 25: 207-214.
61. Robinson CJ, Alanis MC, Wagner CL et al. Plasma 25-hydroxyvitamin D levels in early-onset severe preeclampsia. Am J Obstet Gynecol 2010; 203: 366.e1-e6.
62. Liu NQ, Ouyang Y, Bulut Y et al. Dietary vitamin D restriction in pregnant female mice is associated with maternal hypertension and altered placental and fetal development. Endocrinology 2013; 154: 2270-2280.
63. Faulkner JL, Cornelius DC, Amaral LM et al. Vitamin D supplementation improves pathophysiology in a rat model of preeclampsia. Am J Physiol Regul Integr Comp Physiol 2016; 310: R346-R354.
64. Lykkedegn S, Sorensen GL, Beck-Nielsen SS et al. Vitamin D depletion in pregnancy decreases survival time, oxygen saturation, lung weight and body weight in preterm rat offspring. PLoS One 2016; 11: e0155203.
65. Calton EK, Keane KN, Newsholme P et al. The impact of vitamin D levels on inflammatory status: a systematic review of immune cell studies. PloS One 2015; 10: e0141770.
66. McGrath JJ, Eyles DW, Pedersen CB et al. Neonatal vitamin D status and risk of schizophrenia: a population-based case-control study. Arch Gen Psychiatry 2010; 67: 889-894.
67. LaMarca B, Amaral LM, Harmon AC et al. Placental ischemia and resultant phenotype in animal models of preeclampsia. Curr Hypertens Rep 2016; 18: 38.
68. Gibson CC, Davis CT, Zhu W et al. Dietary vitamin D and its metabolites non-genomically stabilize the endothelium. PLoS One 2015; 10: e0140370.
69. Gibson CC, Zhu W, Davis CT et al. Strategy for identifying repurposed drugs for the treatment of cerebral cavernous malformation. Circulation 2015; 131: 289-299.
70. Black JA, Carter RE. Association between aortic stenosis and facies of severe infantile hypercalcemia. Lancet 1963; 2: 745-749.
71. Garcia RE, Friedman WF, Kaback M et al. Idiopathic hypercalcemia and supravalvular aortic stenosis: documentation of a new syndrome. N Engl J Med 1964; 271: 117-120.
72. Friedman WF. Vitamin D as a cause of the supravalvular aortic stenosis syndrome. Am Heart J 1967; 73: 718-720.
73. Antia AV, Wiltse HE, Rowe RD et al. Pathogenesis of the supravalvular aortic stenosis syndrome. J Pediatr 1967; 71: 431-441.
74. Seelig MS. Vitamin D and cardiovascular, renal and brain damage in infancy and childhood. Ann N Y Acad Sci 1969; 147: 539-582.
75. Latorre G. Effect of overdose of vitamin D2 on pregnancy in the rat. Fertil Steril 1961; 12: 343-345.
76. Friedman WF, Roberts WC. Vitamin D and the supravalvular aortic stenosis syndrome. The transplacental effects of vitamin D on the aorta of the rabbit. Circulation 1966; 34: 77-86.
77. Morris CA, Mervis CB. William's syndrome and related disorders. Annu Rev Genomics Hum Genet 2000; 1: 461-484.
78. Aravena T, Castillo S, Carrasco X et al. Williams syndrome: clinical, cytogenetical, neurophysiological and neuroanatomic study. Rev Med Chil 2002; 130: 631-637.
79. Garabédian M, Jacqz E, Guillozo H et al. Elevated plasma 1,25-dihydroxyvitamin D concentrations in infants with hypercalcemia and an elfin facies. N Engl J Med 1985; 312: 948-952.
80. Becroft DM, Chambers D. Supravalvular aortic stenosis-infantile hypercalcemia syndrome: in vitro hypersensitivitiy to vitamin D and calcium. J Med Genet 1976; 13: 223-228.
81. Taylor AB, Stern PH, Bell NH. Abnormal regulation of circulating 25-hydroxyvitamin D on the Williams Syndrome. N Engl J Med 1982; 306: 972-975.
82. Cooper C, Harvey NC, Bishop NJ et al. Maternal gestational vitamin D supplementation and offspring bone health (MAVIDOS): a multicentre, double-blind, randomised placebo-controlled trial. Lancet Diabetes Endocrinol 2016; 4: 393-402.
83. Olsen SF, Secher NJ. A possible preventive effect of low-dose fish oil on early delivery and pre-eclampsia: indications from a 50-year-old controlled trial. Br J Nutr 1990; 64: 599-609.
84. Bodnar LM, Catov JM, Simhan HN et al. Maternal vitamin D deficiency increases the risk of preeclampsia. J Clin Endorcrinol Metab 2007; 92: 3517-3522.
85. Baker AM, Haeri S, Camargo CA Jr et al. A nested case-control study of midgestation vitamin D deficiency and risk of severe preeclampsia. J Clin Endocrinol Metab 2010; 95: 5105-5109.
86. Gernand AD, Bodnar LM, Klebanoff MA et al. Maternal serum 25- hydroxyvitamin D and placental vascular pathology in a multicenter US cohort. Am J Clin Nutr 2013; 98: 383-388.
87. Merewood A, Mehta SD, Chen TC et al. Association between vitamin D deficiency and primary cesarean section. J Clin Endocrinol Metab 2009; 94: 940-945.
88. Zhang C, Qiu C, Hu FB et al. Maternal plasma 25-hydroxyvitamin D concentrations and the risk for gestational diabetes mellitus. PLoS One 2008; 3: e3753.
89. Bodnar LM, Simhan HN. Vitamin D may be a link to black-white disparities in adverse birth outcomes. Obstet Gynecol Surv 2010; 65: 273-284.
90. Pal L, Zhang H, Williams J et al. Vitamin D status relates to reproductive outcome in women with polycystic ovary syndrome: secondary analysis of a multicenter randomized controlled trial. J Clin Endocrinol Metab 2016; 101: 3027-3035.
91. Miliku K, Vinkhuyzen A, Blanken LM et al. Maternal vitamin D concentrations during pregnancy, fetal growth patterns, and risks of adverse birth outcomes. Am J Clin Nutr 2016; 103: 1514-1522.
92. Hou W, Yan XT, Bai CM et al. Decreased serum vitamin D levels in early spontaneous pregnancy loss. Eur J Clin Nutr 2016; 70: 1004-1008.
93. Lindqvist PG, Silva AT, Gustafsson SA et al. Maternal vitamin D deficiency and fetal distress/birth asphyxia: a population-based nested case-control study. BMJ Open 2016; 6: e009733.
94. Kiely ME, Zhang JY, Kinsella M et al. Vitamin D status is associated with uteroplacental dysfunction indicated by pre-eclampsia and smallfor- gestational-age birth in a large prospective pregnancy cohort in Ireland with low vitamin D status. Am J Clin Nutr 2016; 104: 354-361.
95. Qin LL, Lu FG, Yang SH et al. Does maternal vitamin D deficiency increase the risk of preterm birth: a meta-analysis of observational studies. Nutrients 2016; 8. pii: E301.
96. Hollis B, Wagner C. Assessment of dietary vitamin D requirements during pregnancy and Lactation. Am J Clin Nutr 2004; 79: 717-726.
97. Bodnar LM, Catov JM, Roberts JM. Racial/ethnic differences in the monthly variation of preeclampsia incidence. Am J Obstet Gynecol 2007; 196: 324.e1-e5.
98. Weiss S, Wolsk H, Mirzakhani H et al. Asthma/wheeze and preeclampsia outcomes in the VDAART trial: the influcence of baseline and treatment levels of vitamin D on treatment response. Boston: The Vitamin D Workshop, 2016. Available at: http://www.vitamindworkshop.org/
99. Litonjua AA, Carey VJ, Laranjo N et al. Effect of prenatal supplementation with vitamin D on asthma or recurrent wheezing in offspring by age 3 years: The VDAART Randomized Clinical Trial. JAMA 2016; 315: 362-370.
100. Mirzakhani H, Harshfield B, Carey V et al. (eds). Association of maternal asthma and early pregnancy serum vitamin D level with risk of preeclampsia. Boston: The Vitamin D Workshop. 2016. Available at http://www.vitamindworkshop.org/
101. Wolsk H, Harshfield BJ, Laranjo N et al. (eds). Vitamin D supplementation in pregnant women of different races and the risk of asthma/ recurrent wheeze in the child: findings from the Vitamin D Antenatal Asthma Reduction Trial (VDAART). Boston: The Vitamin D Workshop. 2016. Available at http://www.vitamindworkshop.org/
102. Wolsk H, Litonjua A, Chawes B et al. Prenatal vitamin D supplementation and risk of asthma/wheeze at 3 years of age: a meta-analysis of randomized controlled trials. JAMA 2016; 315: 353-361.
103. Wagner CL, McNeil R, Hamilton SA et al. A randomized trial of vitamin D supplementation in 2 community health center networks in South Carolina. Am J Obstet Gynecol 2013; 208: 137.e1-e13.
104. Wagner CL, Baggerly C, McDonnell S et al. Post-hoc analysis of vitamin D status and reduced risk of preterm birth in two vitamin D pregnancy cohorts compared with South Carolina March of Dimes 2009-2011 rates. J Steroid Biochem Mol Biol 2016; 155: 245-251.
105. Liu PT, Stenger S, Li H et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006; 311: 1770-1773.
106. Fabri M, Stenger S, Shin DM et al. Vitamin D is required for IFN- {gamma}-mediated antimicrobial activity of human macrophages. Sci Transl Med 2011; 3: 104ra102.
107. Liu NQ, Hewison M. Vitamin D, the placenta and pregnancy. Arch Biochem Biophys 2011; 523: 37-47.
108. Lagishetty V, Liu NQ, Hewison M. Vitamin D metabolism and innate immunity. Mol Cell Endocrinol 2011; 347: 97-105.
109. Liu NQ, Kaplan AT, Lagishetty V et al. Vitamin D and the regulation of placental inflammation. J Immunol 2011; 186: 5968-5974.
110. Vieth R. Vitamin D supplementation, 25-hydroxy-vitamin D concentrations, and safety. Am J Clin Nutr 1999; 69: 842-856.
111. Heaney R, Davies K, Chen T et al. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 2003; 77: 204-210.
112. Souberbielle JC, Cormier C, Kindermans C et al. Vitamin D status and redefining serum parathyroid hormone reference range in the elderly. J Clin Endocrinol Metab 2001; 86: 3086-3090.
113. Hollis BW, Wagner CL. Vitamin d and pregnancy: skeletal effects, nonskeletal effects, and birth outcomes. Calcif Tissue Int 2013; 92: 128-139.
114. Wagner CL, McNeil RB, Johnson DD et al. Health characteristics and outcomes of two randomized vitamin D supplementation trials during pregnancy: a combined analysis. J Steroid Biochem Mol Biol 2013; 136: 313-320.
115. Goldring ST, Griffiths CJ, Martineau AR et al. Prenatal vitamin d supplementation and child respiratory health: a randomised controlled trial. PLoS One 2013; 8: e66627.
116. Sablok A, Batra A, Thariani K et al. Supplementation of vitamin D in pregnancy and its correlation with feto-maternal outcome. Clin Endocrinol (Oxf) 2015; 83: 536-541.
117. Mojibian M, Soheilykhah S, Fallah Zadeh MA et al. The effects of vitamin D supplementation on maternal and neonatal outcome: a randomized clinical trial. Iran J Reprod Med 2015; 13: 687-696.
118. Chawes BL, Bonnelykke K, Stokholm J et al. Effect of vitamin D3 supplementation during pregnancy on risk of persistent wheeze in the offspring: a randomized clinical trial. JAMA 2016; 315: 353-361.
119. Grant CC, Crane J, Mitchell EA et al. Vitamin D supplementation during pregnancy and infancy reduces aeroallergen sensitization: a randomized controlled trial. Allergy 2016; 71: 1325-1334.
120. Zhang Q, Cheng Y, He M et al. Effect of various doses of vitamin D supplementation on pregnant women with gestational diabetes mellitus: a randomized controlled trial. Exp Ther Med 2016; 12: 1889-1895.
121. Zerofsky MS, Jacoby BN, Pedersen TL et al. Daily cholecalciferol supplementation during pregnancy alters markers of regulatory immunity, inflammation, and clinical outcomes in a randomized controlled trial. J Nutr 2016; 146: 2388-2397.
122. Brehm JM, Celedon JC, Soto-Quiros ME et al. Serum vitamin D levels and markers of severity of childhood asthma in Costa Rica. Am J Respir Crit Care Med 2009; 179: 765-771.
123. Brehm JM, Schuemann B, Fuhlbrigge AL et al. Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program study. J Allergy Clin Immunol 2010; 126: 52-8 e5.
124. von Mutius E, Martinez FD. Inconclusive results of randomized trials of prenatal vitamin D for asthma prevention in offspring: curbing the enthusiasm. JAMA 2016; 315: 347-348.
125. Oxford Centre for Evidence-based Medicine-Levels of Evidence 2009. Available at http://www.cebm.net/oxford-centre-evidence-basedmedicine- levels-evidence-march-2009/.
126. Zhu H, Wagner C, Pan Y et al. Maternal vitamin D supplementation and cord blood genome-wide DNA methylation analysis. (abstract). Boston: Vitamin D Workshop, 2016. Available at http://www. vitamindworkshop.org/
127. Schulz EV, Cruze L, Wei W et al. Maternal vitamin D sufficiency and reduced placental gene expression in angiogenic biomarkers related to comorbidities of pregnancy. J Steroid Biochem Mol Biol 2017. pii: S0960- 0760(17)30038-9.
128. Al-Garawi A, Carey VJ, Chhabra D et al. The role of vitamin D in the transcriptional program of human pregnancy. PLoS One 2016; 11: e0163832.
129. Mirzakhani H, Litonjua A, Sharma A et al. Higher Vitamin D Levels in Early Pregnancy and Risk of Preeclampsia. Boston: The Vitamin D Workshop, 2016. Available at http://www.vitamindworkshop.org/
130. Kiely M, Zhang J, Kinsella M et al. Vitamin D Status is Associated with Utero-placental Dysfunction in a Large Prospective Pregnancy Cohort with Low 25(OH)D3 and Ubiquitous 3-epi-25(OH)D3 and 25 (OH)D3 and 25(OH)D2. Boston: The Vitamin D Workshop, 2016, Available at http://www.vitamindworkshop.org/
131. Anderson CM, Ralph JL, Johnson L et al. First trimester vitamin D status and placental epigenomics in preeclampsia among Northern Plains primiparas. Life Sci 2015; 129: 10-15.
132. Strid H, Care A, Jansson T et al. Parathyroid hormone-related peptide (38-94) amide stimulates ATP-dependent calcium transport in the Basal plasma membrane of the human syncytiotrophoblast. J Endocrinol 2002; 175: 517-524.
133. Deftos LJ, Burton DW, Brandt DW et al. Neoplastic hormone-producing cells of the placenta produce and secrete parathyroid hormone-related protein. Studies by immunohistology, immunoassay, and polymerase chain reaction. Lab Invest 1994; 71: 847-852.
134. Mokry LE, Ross S, Ahmad OS et al. Vitamin D and risk of multiple sclerosis: a Mendelian randomization study. PLoS Med 2015; 12: e1001866.
135. Whitehouse AJ, Holt BJ, Serralha M et al. Maternal serum vitamin d levels during pregnancy and offspring neurocognitive development. Pediatrics 2012; 129: 485-493.
136. Chen J, Xin K, Wei J et al. Lower maternal serum 25(OH) D in first trimester associated with higher autism risk in Chinese offspring. J Psychosom Res 2016; 89: 98-101.
137. Gould JF, Anderson AJ, Yelland LN et al. Association of cord blood vitamin D with early childhood growth and neurodevelopment. J Paediatr Child Health 2017; 53: 75-83.
138. Patrick RP, Ames BN. Vitamin D hormone regulates serotonin synthesis. Part 1: relevance for autism. FASEB J 2014; 28: 2398-2413.
139. Patrick RP, Ames BN. Vitamin D and the omega-3 fatty acids control serotonin synthesis and action, part 2: relevance for ADHD, bipolar disorder, schizophrenia, and impulsive behavior. FASEB J 2015; 29: 2207-2222.